354 related articles for article (PubMed ID: 34423899)
1. Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights.
Shokoohian B; Negahdari B; Aboulkheyr Es H; Abedi-Valugerdi M; Baghaei K; Agarwal T; Maiti TK; Hassan M; Najimi M; Vosough M
J Cell Mol Med; 2021 Sep; 25(18):8602-8614. PubMed ID: 34423899
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of the advanced HCC: A second revolution by using immunotherapy].
Fartoux L; Rosmorduc O
Biol Aujourdhui; 2018; 212(3-4):85-87. PubMed ID: 30973137
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment including targeted therapy for advanced hepatocellular carcinoma.
Lin J; Wu L; Bai X; Xie Y; Wang A; Zhang H; Yang X; Wan X; Lu X; Sang X; Zhao H
Oncotarget; 2016 Oct; 7(43):71036-71051. PubMed ID: 27626176
[TBL] [Abstract][Full Text] [Related]
4. Potentiality of immunotherapy against hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of advanced hepatocellular carcinoma : Novel agents and role of local therapy].
Parisod L; Duran R; Denys A; Digklia A
Rev Med Suisse; 2017 May; 13(563):1032-1034. PubMed ID: 28636293
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for hepatocellular carcinoma: Current and future.
Johnston MP; Khakoo SI
World J Gastroenterol; 2019 Jun; 25(24):2977-2989. PubMed ID: 31293335
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapeutic approaches for hepatocellular carcinoma.
Longo V; Gnoni A; Casadei Gardini A; Pisconti S; Licchetta A; Scartozzi M; Memeo R; Palmieri VO; Aprile G; Santini D; Nardulli P; Silvestris N; Brunetti O
Oncotarget; 2017 May; 8(20):33897-33910. PubMed ID: 28420805
[TBL] [Abstract][Full Text] [Related]
8. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
Zhu J; Yin T; Xu Y; Lu XJ
J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
[TBL] [Abstract][Full Text] [Related]
9. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
10. Immunological landscape and immunotherapy of hepatocellular carcinoma.
Prieto J; Melero I; Sangro B
Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):681-700. PubMed ID: 26484443
[TBL] [Abstract][Full Text] [Related]
11. Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond.
Kudo M
World J Gastroenterol; 2019 Feb; 25(7):789-807. PubMed ID: 30809080
[TBL] [Abstract][Full Text] [Related]
12. [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
Zhang DZ; Niu JQ
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):834-837. PubMed ID: 31941237
[TBL] [Abstract][Full Text] [Related]
13. [Current treatment in advanced hepatocellular carcinoma and prospects for immuno-oncology therapy].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):561-565. PubMed ID: 28835076
[TBL] [Abstract][Full Text] [Related]
14. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
15. The role of molecular enrichment on future therapies in hepatocellular carcinoma.
Nault JC; Galle PR; Marquardt JU
J Hepatol; 2018 Jul; 69(1):237-247. PubMed ID: 29505843
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma.
Li X; Xu J; Gu X; Chen L; Wu Q; Li H; Bai H; Yang J; Qian J
Front Immunol; 2021; 12():740790. PubMed ID: 34733279
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.
Liu Z; Liu X; Liang J; Liu Y; Hou X; Zhang M; Li Y; Jiang X
Front Immunol; 2021; 12():765101. PubMed ID: 34675942
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospects.
Roudi R; D'Angelo A; Sirico M; Sobhani N
Int Immunopharmacol; 2021 Dec; 101(Pt A):108322. PubMed ID: 34735916
[TBL] [Abstract][Full Text] [Related]
19. Molecular and immunological paradigms of hepatocellular carcinoma: Special reference to therapeutic approaches.
Kabashima A; Shimada S; Shimokawa M; Akiyama Y; Tanabe M; Tanaka S
J Hepatobiliary Pancreat Sci; 2021 Jan; 28(1):62-75. PubMed ID: 33259135
[TBL] [Abstract][Full Text] [Related]
20. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
Fu Y; Liu S; Zeng S; Shen H
J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]